Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy.
Lauren M PachmanBrian E NolanDeidre DeRanieriAmer M KhojahPublished in: Current treatment options in rheumatology (2021)
This often chronic illness targets the cardiovascular system; mortality has decreased from 30 to 1-2% with corticosteroids. New serological biomarkers indicate occult inflammation: ↑CXCL-10 predicts a longer disease course. Some biologic therapies appear promising.